Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
Italy and African Countries scientific cooperation
A specific call of Horizon 2020 promotes cooperation between Europe and Africa for scientific research, funding project for €80 billion between 2014 and 2020: €24.5 billion for strengthening research in science, €22.6 billion for strengthening industrial leadership in innovation and €31 billion addressed to societal challenges, like global warming, sustainable transport, food or renewal energy. Actually, Italy has been active in this field